000283528 001__ 283528
000283528 005__ 20220930130058.0
000283528 0247_ $$2doi$$a10.3389/fnins.2016.00008
000283528 0247_ $$2ISSN$$a1662-453X
000283528 0247_ $$2ISSN$$a1662-4548
000283528 0247_ $$2Handle$$a2128/9913
000283528 0247_ $$2WOS$$aWOS:000368987300001
000283528 0247_ $$2altmetric$$aaltmetric:5059465
000283528 0247_ $$2pmid$$apmid:26858588
000283528 037__ $$aFZJ-2016-01847
000283528 082__ $$a610
000283528 1001_ $$0P:(DE-Juel1)145440$$aKühbach, Katja$$b0$$ufzj
000283528 245__ $$aApplication of an Amyloid Beta Oligomer Standard in the sFIDA Assay
000283528 260__ $$aLausanne$$bFrontiers Research Foundation$$c2016
000283528 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1457439044_1127
000283528 3367_ $$2DataCite$$aOutput Types/Journal article
000283528 3367_ $$00$$2EndNote$$aJournal Article
000283528 3367_ $$2BibTeX$$aARTICLE
000283528 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000283528 3367_ $$2DRIVER$$aarticle
000283528 520__ $$aStill, there is need for significant improvements in reliable and accurate diagnosis for Alzheimer's disease (AD) at early stages. It is widely accepted that changes in the concentration and conformation of amyloid-β (Aβ) appear several years before the onset of first symptoms of cognitive impairment in AD patients. Because Aβ oligomers are possibly the major toxic species in AD, they are a promising biomarker candidate for the early diagnosis of the disease. To date, a variety of oligomer-specific assays have been developed, many of them ELISAs. Here, we demonstrate the sFIDA assay, a technology highly specific for Aβ oligomers developed toward single particle sensitivity. By spiking stabilized Aβ oligomers to buffer and to body fluids from control donors, we show that the sFIDA readout correlates with the applied concentration of stabilized oligomers diluted in buffer, cerebrospinal fluid (CSF), and blood plasma over several orders of magnitude. The lower limit of detection was calculated to be 22 fM of stabilized oligomers diluted in PBS, 18 fM in CSF, and 14 fM in blood plasma.
000283528 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000283528 588__ $$aDataset connected to CrossRef
000283528 7001_ $$0P:(DE-Juel1)145968$$aHülsemann, Maren$$b1$$ufzj
000283528 7001_ $$0P:(DE-Juel1)159122$$aHerrmann, Yvonne$$b2$$ufzj
000283528 7001_ $$0P:(DE-Juel1)136806$$aKravchenko, Kateryna$$b3$$ufzj
000283528 7001_ $$0P:(DE-Juel1)162310$$aKulawik, Andreas$$b4$$ufzj
000283528 7001_ $$0P:(DE-Juel1)145159$$aLinnartz, Christina$$b5$$ufzj
000283528 7001_ $$0P:(DE-Juel1)145123$$aPeters, Luriano$$b6$$ufzj
000283528 7001_ $$0P:(DE-Juel1)144117$$aWang, Kun$$b7
000283528 7001_ $$0P:(DE-Juel1)159192$$aWillbold, Johannes$$b8$$ufzj
000283528 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b9$$ufzj
000283528 7001_ $$0P:(DE-Juel1)157832$$aBannach, Oliver$$b10$$eCorresponding author$$ufzj
000283528 773__ $$0PERI:(DE-600)2411902-7$$a10.3389/fnins.2016.00008$$gVol. 10$$p8$$tFrontiers in neuroscience$$v10$$x1662-453X$$y2016
000283528 8564_ $$uhttps://juser.fz-juelich.de/record/283528/files/Application%20of%20an%20Amyloid%20Beta%20Oligomer%20Standard%20in%20the%20sFIDA%20Assay.pdf$$yOpenAccess
000283528 8564_ $$uhttps://juser.fz-juelich.de/record/283528/files/Application%20of%20an%20Amyloid%20Beta%20Oligomer%20Standard%20in%20the%20sFIDA%20Assay.gif?subformat=icon$$xicon$$yOpenAccess
000283528 8564_ $$uhttps://juser.fz-juelich.de/record/283528/files/Application%20of%20an%20Amyloid%20Beta%20Oligomer%20Standard%20in%20the%20sFIDA%20Assay.jpg?subformat=icon-1440$$xicon-1440$$yOpenAccess
000283528 8564_ $$uhttps://juser.fz-juelich.de/record/283528/files/Application%20of%20an%20Amyloid%20Beta%20Oligomer%20Standard%20in%20the%20sFIDA%20Assay.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000283528 8564_ $$uhttps://juser.fz-juelich.de/record/283528/files/Application%20of%20an%20Amyloid%20Beta%20Oligomer%20Standard%20in%20the%20sFIDA%20Assay.jpg?subformat=icon-640$$xicon-640$$yOpenAccess
000283528 8564_ $$uhttps://juser.fz-juelich.de/record/283528/files/Application%20of%20an%20Amyloid%20Beta%20Oligomer%20Standard%20in%20the%20sFIDA%20Assay.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000283528 8767_ $$92016-05-10$$d2016-05-10$$eAPC$$jDeposit$$lDeposit: Frontiers$$zUSD 1.311,-
000283528 909CO $$ooai:juser.fz-juelich.de:283528$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145440$$aForschungszentrum Jülich GmbH$$b0$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145968$$aForschungszentrum Jülich GmbH$$b1$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)159122$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)136806$$aForschungszentrum Jülich GmbH$$b3$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)162310$$aForschungszentrum Jülich GmbH$$b4$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145159$$aForschungszentrum Jülich GmbH$$b5$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145123$$aForschungszentrum Jülich GmbH$$b6$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)159192$$aForschungszentrum Jülich GmbH$$b8$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich GmbH$$b9$$kFZJ
000283528 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)157832$$aForschungszentrum Jülich GmbH$$b10$$kFZJ
000283528 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000283528 9141_ $$y2016
000283528 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000283528 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000283528 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000283528 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000283528 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT NEUROSCI-SWITZ : 2014
000283528 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000283528 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000283528 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000283528 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000283528 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000283528 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000283528 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000283528 920__ $$lyes
000283528 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000283528 9801_ $$aUNRESTRICTED
000283528 9801_ $$aFullTexts
000283528 980__ $$ajournal
000283528 980__ $$aVDB
000283528 980__ $$aUNRESTRICTED
000283528 980__ $$aI:(DE-Juel1)ICS-6-20110106
000283528 980__ $$aAPC
000283528 981__ $$aI:(DE-Juel1)IBI-7-20200312